Christopher is Co-Head of the Nordics and a Partner of Bridgepoint Europe responsible for its investment activity in the Nordic region. He is a member of the Technology Sector team. He joined Bridgepoint in 2007.

He currently sits on the boards of Cherry, Diaverum and Vitamin Well. He has worked on a number of transactions including Vitamin Well, Cherry, Evac, Nordic Cinema Group, Trustly and Terveystalo.

Prior to joining Bridgepoint he worked in the investment banking division of UBS in London where he was involved in a number of cross border transactions.

Christopher has an MSc in Business Administration and Finance from Stockholm University, School of Business.

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.